Article
CYP3A5 and POR gene polymorphisms as predictors of infection and graft rejection in post-liver transplant patients treated with tacrolimus - a cohort study
2023-10-09
Abstract excerpt
<title>Abstract</title> <p>Liver transplantation is the only curative option for patients with advanced stages of liver disease, with tacrolimus used as the immunosuppressive drug of choice. However, due to its narrow therapeutic index and high inter- and intra-individual variability, serum monitoring should be frequent. An individual's genetic variability can interfere with drug response, potentially leading an...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 3d78651b-df6d-5839-8f47-986471457b01
- DOI
- 10.21203/rs.3.rs-3399704/v1
